Dynamic insulin on board: Incorporation of circadian insulin sensitivity variation

Journal of Diabetes Science and Technology

Volumn 7, Issue 4, 2013, Pages 928-940

  Toffanin, Chiara ^a   Zisser, Howard ^b,c   Doyle III, Francis J ^b,c   Dassau, Eyal ^b,c  

^a UNIVERSITY OF PAVIA   (Italy)

^b SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^c University of California   (United States)

Author keywords

Artificial pancreas; Circadian rhythm; Continuous subcutaneous insulin infusion; Diabetes; Insulin on board; Insulin sensitivity

Indexed keywords

CARBOHYDRATE; GLUCOSE; INSULIN;

ANALYTIC METHOD; ARTICLE; BODY WEIGHT; CIRCADIAN RHYTHM; DYNAMIC INSULIN ON BOARD ESTIMATION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN SENSITIVITY; NOCTURNAL HYPOGLYCEMIA; PHYSICAL ACTIVITY; STRESS; ADULT; INSULIN INFUSION; INSULIN RESISTANCE; METABOLISM; OBSERVER VARIATION; PERSONALIZED MEDICINE; PHYSIOLOGY; PROCEDURES; METHODOLOGY;

ADULT; CIRCADIAN RHYTHM; HUMANS; INDIVIDUALIZED MEDICINE; INSULIN; INSULIN INFUSION SYSTEMS; INSULIN RESISTANCE; OBSERVER VARIATION;

EID: 84897118324     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681300700415     Document Type: Article

References (26)

1. Ziel FH, Davidson MB, Harris MD, Rosenberg CS. The variability in the action of unmodified insulin is more dependent on changes in tissue insulin sensitivity than on insulin absorption. Diabet Med. 1988;5(7):662-6.
2. Simon C, Weibel L, Brandenberger G. Twenty-four-hour rhythms of plasma glucose and insulin secretion rate in regular night workers. Am J Physiol Endocrinol Metab. 2000;278(3):E413-20. (Pubitemid 30149385)
3. Heinemann L, Nosek L, Kapitza C, Schweitzer MA, Krinelke L. Changes in basal insulin infusion rates with subcutaneous insulin infusion: time until a change in metabolic effect is induced in patients with type 1 diabetes. Diabetes Care. 2009;32(8):1437-9.
4. Hinshaw L, Man CD, Nandy DK, Saad A, Bharucha AE, Levine JA, Rizza RA, Basu R, Carter RE, Cobelli C, Kudva YC, Basu A. Diurnal pattern of insulin action in type 1 diabetes: implications for a closed loop system. Diabetes. 2013. Epub ahead of print.
5. Vlachokosta FV, Piper CM, Gleason R, Kinzel L, Kahn CR. Dietary carbohydrate, a Big Mac, and insulin requirements in type I diabetes. Diabetes Care. 1988;11(4):330-6.
6. Mejean L, Bicakova-Rocher A, Kolopp M, Villaume C, Levi F, Debry G, Reinberg A, Drouin P. Circadian and ultradian rhythms in blood glucose and plasma insulin of healthy adults. Chronobiol Int. 1988;5(3):227-36.
7. Perriello G, De Feo P, Torlone E, Fanelli C, Santeusanio F, Brunetti P, Bolli GB. Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia. 1990;33(1):52-9. (Pubitemid 20035474)
8. Rizza RA, Gerich JE, Haymond MW, Westland RE, Hall LD, Clemens AH, Service FJ. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. N Engl J Med. 1980;303(23):1313-8. (Pubitemid 11194455)
9. Nestler JE, Gebhart SS, Blackard WG. Failure of a midnocturnal insulin infusion to suppress the increased insulin need for breakfast in insulindependent diabetic patients. Diabetes. 1984;33(3):266-70. (Pubitemid 14196217)
10. Atiea JA, Aslan SM, Owens DR, Luzio S. Early morning hyperglycaemia "dawn phenomenon" in non-insulin dependent diabetes mellitus (NIDDM): efects of cortisol suppression by metyrapone. Diabetes Res. 1990;14(4):181-5.
11. Perriello G, De Feo P, Torlone E, Fanelli C, Santeusanio F, Brunetti P, Bolli GB. The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity. Diabetologia. 1991;34(1):21-8.
12. Clarke WL, Haymond MW, Santiago JV. Overnight basal insulin requirements in fasting insulin-dependent diabetics. Diabetes. 1980;29(1):78-80. (Pubitemid 10157194)
13. Scheen AJ, Van Cauter E. The roles of time of day and sleep quality in modulating glucose regulation: clinical implications. Horm Res. 1998;49(3-4):191-201. (Pubitemid 28138337)
14. Jarrett RJ, Baker IA, Keen H, Oakley NW. Diurnal variation in oral glucose tolerance: blood sugar and plasma insulin levels morning, afternoon, and evening. Br Med J. 1972;1(5794):199-201.
15. Van Cauter E, Polonsky KS, Scheen AJ. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev. 1997;18(5):716-38. (Pubitemid 27435542)
16. Fischer U, Freyse EJ, Albrecht G, Gebel G, Heil M, Unger W. Daily glucose and insulin rhythms in diabetic dogs on the artificial beta cell. Exp Clin Endocrinol. 1985;85(1):27-37. (Pubitemid 15105739)
17. Cotterill AM, Daly F, Holly JM, Hughes SC, Camacho-Hübner C, Abdulla AF, Gale EA, Savage MO. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1. Clin Endocrinol (Oxf). 1995;43(5):567-74.
18. Zisser H, Robinson L, Bevier W, Dassau E, Ellingsen C, Doyle FJ, Jovanovic L. Bolus calculator: a review of four "smart" insulin pumps. Diabetes Technol Ther. 2008;10(6):441-4.
19. Perriello G, De Feo P, Bolli GB. The dawn phenomenon: nocturnal blood glucose homeostasis in insulin-dependent diabetes mellitus. Diabet Med. 1988;5(1):13-21. (Pubitemid 18018816)
20. Patek SD, Magni L, Dassau E, Karvetski C, Tofanin C, De Nicolao G, Del Favero S, Breton M, Man CD, Renard E, Zisser H, Doyle FJ 3rd, Cobelli C, Kovatchev BP; International Artificial Pancreas (iAP) Study Group. Modular closed-loop control of diabetes. IEEE Trans Biomed Eng. 2012;59(11):2986-99.
21. Trümper BG, Reschke K, Molling J. Circadian variation of insulin requirement in insulin dependent diabetes mellitus the relationship between circadian change in insulin demand and diurnal patterns of growth hormone, cortisol and glucagon during euglycemia. Horm Metab Res. 1995;27(3):141-7.
22. Yamamoto H, Nagai K, Nakagawa H. Role of SCN in daily rhythms of plasma glucose, FFA, insulin and glucagon. Chronobiol Int. 1987;4(4):483-91.
23. Ellingsen C, Dassau E, Zisser H, Grosman B, Percival MW, Jovanovic L, Doyle FJ 3rd. Safety constraints in an artificial pancreatic beta cell: an implementation of model predictive control with insulin on board. J Diabetes Sci Technol. 2009;3(3):536-44.
24. Kovatchev BP, Breton M, Man CD, Cobelli C. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol. 2009;3(1):44-55.
25. Cobelli C, Man CD, Sparacino G, Magni L, De Nicolao G, Kovatchev BP. Diabetes: models, signals, and control. IEEE Rev Biomed Eng. 2009;2:54-96.
26. Magni L, Raimondo DM, Man CD, Breton M, Patek S, Nicolao GD, Cobelli C, Kovatchev BP. Evaluating the eficacy of closed-loop glucose regulation via control-variability grid analysis. J Diabetes Sci Technol. 2008;2(4):630-5.